Oncology Meeting Resources

In this section, you can find all available abstracts, presentations and webcasts on OncologyPRO.

Here below, you can search across all meeting resources by session title, presentation title, presenter or keyword. Results can then be refined by topic, event and publication date.

The use of these presentations is for personal educational purposes only.
ESMO thanks the authors for their generosity.




Format available

http://oncologypro.esmo.org/Meeting-Resources/ESMO-Asia-2017-Congress/Brain-Tumours

Date: 19 Nov 2017
Presenter: Rakesh Jalali
Resources: Presentation, Webcast
Topics: Central Nervous System Malignancies, Surgery and/or Radiotherapy of Cancer

http://oncologypro.esmo.org/Meeting-Resourc...oblastoma-multiforme-SEER-based-cohort.-118O

BackgroundGlioblastoma (GBM) is the most common and fatal primary brain tumor in adults. Therefore, there is interest in conducting clinical trials of experimental treatments on patients with GBM, where...

Date: 19 Nov 2017
Presenter: Ninos Nissan
Resources: Abstract
Topic: Central Nervous System Malignancies

http://oncologypro.esmo.org/Meeting-Resourc...-by-regulation-of-IDH1-R132H-expression-553P

BackgroundCyclin F (CCNF) is the substrate recognition component of the SCF complex, which functions as an E3 ubiquitin ligase. A previous report has described the downregulation of CCNF in hepatocellular carcinoma.

Date: 18 Nov 2017
Presenter: Ruhi Deshmukh
Resources: Abstract
Topics: Central Nervous System Malignancies, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...eat-shock-protein-protective-mechanisms-120P

BackgroundGlioblastoma Multiforme (GBM) is an aggressive brain cancer associated with high mortality. Current treatments including resection of 98% or more of the tumour result in median survival of less than 15 months.

Date: 18 Nov 2017
Presenter: Tsz Wai Rosita Pang
Resources: Abstract
Topics: Central Nervous System Malignancies, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...ipotency-in-cancer-stem-cells-of-glioma-121P

BackgroundSIRT1, a class III histone deacetylase has cancer relevance because it regulates lifespan in multiple organisms and down-regulates p53 function through deacetylation.

Date: 18 Nov 2017
Presenter: mohita bhagat
Resources: Abstract
Topics: Basic Science, Central Nervous System Malignancies

http://oncologypro.esmo.org/Meeting-Resourc...primary-central-nervous-system-lymphoma-122P

BackgroundPrimary central nervous system lymphoma (PCNSL) is a rare cancer accounting for less than 3% of primary brain and central nervous system (CNS) tumors. Tissues involved include the brain...

Date: 18 Nov 2017
Presenter: Hao Long
Resources: Abstract
Topics: Anti-Cancer Agents & Biologic Therapy, Central Nervous System Malignancies, Surgery and/or Radiotherapy of Cancer

http://oncologypro.esmo.org/Meeting-Resourc...AT1-expression-via-NFkB-in-glioblastoma-123P

BackgroundGlioblastoma (GBM) is the most aggressive brain cancer. Curcumin, a natural dietary polyphenol extracted from Curcuma longa L, has a demonstrated promising outcome against the GBM.

Date: 18 Nov 2017
Presenter: Chitrangda Srivastava
Resources: Abstract
Topics: Central Nervous System Malignancies, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...emoradiation-on-Outcome-of-Glioblastoma-125P

BackgroundGlioblastoma multiforme (GBM) is the most common, malignant primary brain tumor. Surgical resection followed by concurrent Chemoradiation (CCRT) and adjuvant chemotherapy is the standard treatment at this time.

Date: 18 Nov 2017
Presenter: Abdullah Al Alhumiqani
Resources: Abstract
Topics: Anti-Cancer Agents & Biologic Therapy, Central Nervous System Malignancies, Surgery and/or Radiotherapy of Cancer

http://oncologypro.esmo.org/Meeting-Resourc...Tangerang-Indonesia-A-Preliminary-Study-126P

BackgroundDespite the advancement of microsurgery and other skull base techniques, complete resection of skull base meningiomas still remains a challenge for neurosurgeons.

Date: 18 Nov 2017
Presenter: Prio Wibisono
Resources: Abstract
Topics: Central Nervous System Malignancies, Surgery and/or Radiotherapy of Cancer

http://oncologypro.esmo.org/Meeting-Resourc...eatment-of-recurrent-high-grade-gliomas-127P

BackgroundHigh-grade gliomas (HGGs) are the most common and aggressive group of primary central nervous system (CNS) tumors. They are characterized by diffuse parenchymal infiltration and prominent angiogenesis.

Date: 18 Nov 2017
Presenter: Xiaodong Jiang
Resources: Abstract
Topics: Anti-Cancer Agents & Biologic Therapy, Central Nervous System Malignancies